文献速递糖尿病

极年幼1型糖尿病风险儿童可通过连续血糖监测发现早期血糖异常

Early Dysglycemia Is Detectable Using Continuous Glucose Monitoring in Very Young Children at Risk of Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2024-01-01

本研究在澳大利亚ENDIA队列中,对31名持续多种胰岛自身抗体阳性(PM Ab+)儿童和24名年龄匹配对照儿童进行连续血糖监测(CGM)。PM Ab+儿童血糖标准差、变异系数及血糖>7.8 mmol/L时间百分比均高于对照,平均传感器血糖无显著差异。CGM在极年幼T1D风险儿童中可行且耐受良好。

要点

  • PM Ab+儿童血糖标准差中位数1.1 mmol/L,高于对照的0.9 mmol/L(P<0.001)。
  • PM Ab+儿童血糖变异系数中位数17.3%,高于对照的14.7%(P<0.001)。
  • PM Ab+儿童血糖>7.8 mmol/L时间百分比中位数8.0%,高于对照的3.3%(P=0.005)。

核心结论

  • CGM在极年幼T1D风险儿童中可行且耐受良好。
  • 极年幼PM Ab+儿童血糖标准差、变异系数及血糖>7.8 mmol/L时间百分比升高,与既往涉及年长参与者的研究一致。

研究设计与样本

  • 研究纳入澳大利亚ENDIA研究中从出生纵向观察至10岁的儿童。
  • 2021年1月至2023年6月,31名持续多种胰岛自身抗体阳性(PM Ab+)儿童和24名年龄匹配对照儿童接受CGM评估及标准临床监测。

主要发现

  • PM Ab+组和Ab-组平均(SD)年龄分别为4.4(1.8)岁和4.7(1.9)岁。
  • 86%符合条件的PM Ab+儿童同意佩戴CGM,中位(Q1,Q3)传感器佩戴时间为12.5(9.0,15.0)天。
  • PM Ab+组血糖标准差中位(Q1,Q3)为1.1(0.9,1.3)mmol/L,高于Ab-组的0.9(0.8,1.0)mmol/L(P<0.001)。
  • PM Ab+组血糖变异系数中位(Q1,Q3)为17.3%(16.0,20.9),高于Ab-组的14.7%(12.9,16.6)(P<0.001)。
  • PM Ab+组血糖>7.8 mmol/L时间百分比中位(Q1,Q3)为8.0%(4.4,13.0),高于Ab-组的3.3%(1.4,5.3)(P=0.005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Continuous glucose monitoring (CGM) can detect early dysglycemia in older children and adults with presymptomatic type 1 diabetes (T1D) and predict risk of progression to clinical onset. However, CGM data for very young children at greatest risk of disease progression are lacking. This study aimed to investigate the use of CGM data measured in children being longitudinally observed in the Australian Environmental Determinants of Islet Autoimmunity (ENDIA) study from birth to age 10 years. RESEARCH DESIGN AND METHODS: Between January 2021 and June 2023, 31 ENDIA children with persistent multiple islet autoimmunity (PM Ab+) and 24 age-matched control children underwent CGM assessment alongside standard clinical monitoring. The CGM metrics of glucose SD (SDSGL), coefficient of variation (CEV), mean sensor glucose (SGL), and percentage of time >7.8 mmol/L (>140 mg/dL) were determined and examined for between-group differences. RESULTS: The mean (SD) ages of PM Ab+ and Ab- children were 4.4 (1.8) and 4.7 (1.9) years, respectively. Eighty-six percent of eligible PM Ab+ children consented to CGM wear, achieving a median (quartile 1 [Q1], Q3) sensor wear period of 12.5 (9.0, 15.0) days. PM Ab+ children had higher median (Q1, Q3) SDSGL (1.1 [0.9, 1.3] vs. 0.9 [0.8, 1.0] mmol/L; P < 0.001) and CEV (17.3% [16.0, 20.9] vs. 14.7% [12.9, 16.6]; P < 0.001). Percentage of time >7.8 mmol/L was greater in PM Ab+ children (median [Q1, Q3] 8.0% [4.4, 13.0] compared with 3.3% [1.4, 5.3] in Ab- children; P = 0.005). Mean SGL did not differ significantly between groups (P = 0.10). CONCLUSIONS: CGM is feasible and well tolerated in very young children at risk of T1D. Very young PM Ab+ children have increased SDSGL, CEV, and percentage of time >7.8 mmol/L, consistent with prior studies involving older participants.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Haynes A, Tully A, Smith GJ, et al. Early Dysglycemia Is Detectable Using Continuous Glucose Monitoring in Very Young Children at Risk of Type 1 Diabetes. Diabetes Care. 2024. PMID: 39159241. doi:10.2337/dc24-0540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。